Worst POS stock I have ever bought in my life...ever. Bought at $19....down to a buck, probably a sub penny stock eventually. Crappy management, crappy r&d....just pos, period. Don't buy now. Wait until it's on the OTC at $0.0015, might be able to double your money if you dump at $0.003
This is second HBV compound ABUS has killed off in the past few months—in Oct 2019 ABUS terminated AB-506, a capsid inhibitor, due to a safety problem (#msg-151513575).
What’s left in ABUS’ pipeline? ABS-452, an injected RNA destabilizer, is in phase-1; and ABS-836 (the successor to the terminated AB-506), a capsid inhibitor*, is in preclinical development with phase-1 anticipated in 2021.
ABUS is down “only” 6% on today’s PR because it has been known for over a year that AB-452 had a safety issue.
-- *ENTA (#msg-153696410) and ASMB (#msg-148672065) are also developing an HBV capsid inhibitor (a/k/a “core” inhibitor or CpAM).